Showing results (11-20 of 62) with videos related to
Sort By:
Pageof 7
Pediatric Hematology and Oncology|January 1, 1997
Beta-thalassemia alleles in Aegean region of Turkey: effect on clinical severity of diseaseG Nişli, K Kavakli, Y Aydinok, et al.Minerva Pediatrica|February 12, 2011
Complete clinical recovery of a central pontine and extrapontine myelinolysis delayed onset in a child with acute myeloblastic leukemiaD Yilmaz, B Karapinar, C Balkan, et al.Journal of Tropical Pediatrics|December 1, 1996
Recombinant human erythropoietin trial in thalassemia intermediaG Nişli, K Kavakli, C Vergin, et al.Pediatric Hematology and Oncology|March 1, 1997
Serum erythropoietin levels in patients with beta thalassemia major and intermediaG Nişli, K Kavakli, Y Aydinok, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|September 14, 2001
Intraleucocyte platelet-activating factor levels in desmopressin-treated patients with haemophilia A and von Willebrand diseaseK Kavakli, A Hüseyinov, I Coker, et al.Acta Paediatrica (Oslo, Norway : 1992)|November 18, 2000
Lupus anticoagulant and protein S deficiency in otherwise healthy children with acute varicella infectionZ Kurugöl, F Vardar, F Ozkinay, et al.The Thoracic and Cardiovascular Surgeon|August 27, 2009
Primary pulmonary paraganglioma with Hodgkin's lymphomaK Kavakli, M Ozturk, O Ongoru, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|May 21, 2016
Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in subjects with hereditary factor X deficiencyS K Austin, K Kavakli, M Norton, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|February 17, 2016
Pharmacokinetics of a high-purity plasma-derived factor X concentrate in subjects with moderate or severe hereditary factor X deficiencyS K Austin, C Brindley, K Kavakli, et al.The Turkish Journal of Pediatrics|July 1, 1997
Histiocytic syndromes in childrenN Cetingül, S Oztop, K Kavakli, et al.Pageof 7